Filing Details

Accession Number:
0000899243-22-017785
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-12 17:25:45
Reporting Period:
2022-05-10
Accepted Time:
2022-05-12 17:25:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1762144 Gerard Ber C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-10 1,277 $58.19 32,703 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The Company withheld 1,277 shares to satisfy tax withholding obligations resulting from the vesting of restricted stock units.